-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
-
Summary
-
Ambrx Biopharma Cayman, Inc. quarterly Accounts Payable, Current history and change rate from Q4 2020 to Q2 2023.
- Ambrx Biopharma Cayman, Inc. Accounts Payable, Current for the quarter ending 30 Jun 2023 was $6,362,000.000, a 11.7% increase year-over-year.
Accounts Payable, Current, Quarterly (USD)
Accounts Payable, Current, YoY Quarterly Change (%)